PLx Pharma Inc.
PLXP · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $26 | $36 | $52 | $69 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $1 | $1 |
| Inventory | $3 | $4 | $4 | $2 |
| Other Curr. Assets | $1 | $1 | $1 | $1 |
| Total Curr. Assets | $30 | $41 | $58 | $73 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $1 |
| Goodwill | $2 | $2 | $2 | $2 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $3 | $3 | $3 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $33 | $45 | $61 | $77 |
| Liabilities | – | – | – | – |
| Payables | $5 | $8 | $13 | $11 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $1 | $1 | $1 |
| Total Curr. Liab. | $6 | $9 | $13 | $12 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $3 | $6 | $13 |
| Total NC Liab. | $1 | $3 | $6 | $13 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $7 | $12 | $19 | $25 |
| Equity | – | – | – | – |
| Pref Stock | $16 | $16 | $16 | $16 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$179 | -$171 | -$159 | -$148 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $190 | $187 | $185 | $184 |
| Total Equity | $26 | $33 | $42 | $52 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $33 | $45 | $61 | $77 |
| Net Debt | -$26 | -$36 | -$52 | -$69 |